Function and expression of CD44 during spreading, migration, and invasion of murine carcinoma cells

Experimental Cell Research

Volumn 242, Issue 2, 1998, Pages 515-527

  Ladeda, Virginia ^a,b   Aguirre Ghiso, Julio A ^a   Bal de Kier Joffé, Elisa ^a  

^a UNIVERSIDAD DE BUENOS AIRES   (Argentina)

^b Instituto de Oncologia Angel H Roffo   (Argentina)

Author keywords

Adhesion molecules; Cell motility; Cell signaling; Phorbol esters; Phosphatidic acid

Indexed keywords

HERMES ANTIGEN;

ANIMAL CELL; ANTIGEN EXPRESSION; ARTICLE; CANCER CELL CULTURE; CARCINOMA CELL; CELL ADHESION; CELL INVASION; CELL MIGRATION; CELL SPREADING; CONTROLLED STUDY; IMMUNOCYTOCHEMISTRY; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN LOCALIZATION;

ANIMALIA; MURINAE;

EID: 0032146825     PISSN: 00144827     EISSN: None     Source Type: Journal    
DOI: 10.1006/excr.1998.4094     Document Type: Article

References (48)

1. Brodt P. Adhesion receptors and proteolytic mechanisms in cancer invasion an metastasis. Cell Adhesion and Invasion in Cancer Metastasis. 1996;Landes, Austin. p. 167-242.
2. Aguirre Ghiso J., Farías E., Alonso D., Arregui C., Bal de Kier Joffé E. A phospholipase D and protein kinase C inhibitor blocks the spreading of murine mammary adenocarcinoma cells altering f-actin and b1-integrin point contact distribution. Int. J. Cancer. 71:1997;881-890.
3. Hardingham T., Fosang A. Proteoglycans: many forms and many functions. FASEB J. 6:1992;861-870.
4. Aruffo A., Stamenkovic I., Melnick M., Underhill C., Seed B. CD44 is the principal cell surface receptor for hyaluronate. Cell. 61:1990;1303-1313.
5. Miyake K., Medina K. L., Hayashi S. I., Ono S., Hamaoka T., Kincade P. W. Monoclonal antibodies to Pgp-1/CD44block lymphohemopoiesis in log term bone marrow cultures. J. Exp. Med. 171:1990;477-488.
6. Faasen A. E., Schrager J. A., Klein D. J., Oegema T. R., Couchman J. R., McCarthy J. B. A cell surface chondroitin sulfate proteoglycan, immunologically related to CD44, is involved in type I collagen-mediated melanoma cell motility and invasion. J. Cell Biol. 116:1992;521-531.
7. Jalkanen S., Jalkanen M. Lymphocyte CD44 binds the COOH- terminal heparin-binding domain of fibronectin. J. Cell Biol. 116:1992;817-825.
8. Tolg C., Hofmann M., Herrlich P., Ponta H. Splicing choice from ten variant exons establishes CD44 variability. Nucleic Acids Res. 21:1993;1225-1229.
9. Jalkanen S., Bargatze J., Butcher. Lymphocyte recognition of high endothelium: Antibodies to distinct epitopes of an 85-95 kD glycoprotein antigen differentially inhibit lymphocyte binding to lymph node, mucosal, or synovial endothelial cells. J. Cell Biol. 105:1987;983-990.
10. Gunthert U., Hofmann M., Rudy W., Reber S., Zoller M., Hausmann I., Matzku S., Wenzel A., Ponta H., Herrlich P. A new variant glycoprotein of CD44 confers metastatic potential to rat carcinoma cells. Cell. 65:1991;13-24.
11. Kalomiris E. L., Bourguignon L. Y. W. Lymphoma protein kinase C is associated with the transmembrane glycoprotein, GP85 and may function in GP85-ankyrin binding. J. Biol. Chem. 264:1989;8113-8119.
12. Lokeshwar V. B., Fregien N., Bourguignon L. Y. W. Ankyrin binding domain of CD44 (GP85) is required for the expression of hyaluronic acid-mediated adhesion function. J. Cell Biol. 126:1994;1099-1109.
13. Tsukita S., Kumiki O., Sato N., Sagara J., Kawai A., Tsukita S. ERM family members as molecular linkers between the cell surface glycoprotein CD44 and actin-based cytoskeletons. J. Cell Biol. 126:1994;391-401.
14. Murphy T. L., Dechker G., August J. T. Glycoproteins of coated pits, cell junctions and the entire cell surface revealed by monoclonal antibodies and immunoelectron microscopy. J. Cell Biol. 97:1983;553-541.
15. Jacobson K., O'Dell D., Holifield B., Murphy T. L., August J. T. Redistribution of a major cell surface glycoprotein during cell movement. J. Cell Biol. 99:1984;1613-1623.
16. Tanabe K. K., Ellis L. M., Sayer H. Expression of CD44R1 adhesion molecule in colon carcinomas and metastases. Lancet. 341:1993;725-726.
17. Wielenga V. J., Heider K., Offerhau G., Adolf G., van den Berg F., Ponta H., Herrlich P., Pals S. Expression of CD44 variant proteins in human colorectal cancer is related to tumor progression. Cancer Res. 53:1993;4754-4756.
18. Hofmann M., Rudy W., Zoller M., Tolg C., Ponta H., Herrlich P., Gunthert U. CD44 splice variants confer metastatic behavior in rats: Homologous sequences are expressed in human tumor cell lines. Cancer Res. 51:1991;5292-5297.
19. Heider K. H., Hofmann M., Hors E., van den Berg F., Ponta H., Herrlich P., Pals S. T. A human homologue of the rat metastasis-associated variant of CD44 is expressed in colorectal carcinomas and adenomatous polyps. J. Cell Biol. 120:1993;227-233.
20. Dall P., Heider K., Hekele A., von Minckwitz G., Kaufmann M., Ponta H., Herrlich P. Surface protein expression and mRNA splicing analysis of CD44 in uterine cervical cancer and normal cervical epithelium. Cancer Res. 54:1994;3337-3341.
21. Foster D. Intracellular signaling mediated by protein-tyrosine kinases: Networking through phospholipid metabolism. Cell Signal. 5:1993;389-399.
22. Jamal H., Cano-Gauchi D., Buick R., Filmus J. Activated ras and src induce CD44 overexpression in rat intestinal epithelial cells. Oncogene. 9:1994;417-423.
23. Exton J. Phosphatidylcholine breakdown and signal transduction. Biochim. Biophys. Acta. 1212:1994;26-42.
24. Zhang M., Singh R., Wang M., Wells A., Siegal G. Epidermal growth factor modulates cell attachment to hyaluronic acid by the cell surface glycoprotein CD44. Clin. Exp. Metastasis. 14:1996;268-276.
25. Alonso D., Farías E., Urtreger A., Ladeda V., Vidal M., Bal de Kier Joffé E. Characterization of F3II, a sarcomatoid mammary carcinoma cell line originated from a clonal subpopulation of a mouse adenocarcinoma. J. Surg. Oncol. 62:1996;288-297.
26. Tawil N., Gowri V., Djoneidi M., Nip J., Carbonetto S., Brodt P. Integrin b1 can promote adhesion and spreading of metastatic breast carcinoma cells on the lymph-node stroma. Int. J. Cancer. 66:1996;703-710.
27. Towle M., Lee A., Maduakor E., Schwartz E., Bridges A., Littlefield B. Inhibition of urokinase by 4-substituted benzo [b]thiophene-2-carboxamidines: An important new class of selective synthetic urokinase inhibitor. Cancer Res. 53:1993;2553-2559.
28. Laemmli U. Cleavage of structural proteins during assembly of the head of bacteriophage T4. Nature. 227:1970;680-685.
29. Stahl A., Mueller B. Melanoma cell migration on vitronectin: Regulation by components of the plasminogen activation system. Int. J. Cancer. 71:1997;116-122.
30. Mizuno K., Noda K., Ueda Y., Hanaki H., Saido T., Ikuta T., Kuroki T., Tamaoki T., Hirai S., Osada S., Ohno S. UCN-01, an antitumor drug is a selective inhibitor of conventional PKC subfamily. FEBS Lett. 359:1995;259-261.
31. Blobe G., Obeid M., Hannun Y. Regulation of protein kinase C and role in cancer biology. Cancer Metastasis Rev. 13:1994;411-431.
32. Jiang H., Lu Z., Zang Q., Foster D. Regulation of phosphatidic acid phosphohydrolase by epidermal growth factor. J. Biol. Chem. 271:1996;29529-29532.
33. Aguirre Ghiso J., Alonso D., Farías E., Bal de Kier Joffé E. Overproduction of urokinase-type plasminogen activator is regulated by phospholipase D- and protein kinase C-dependent pathways in murine mammary adenocarcinoma cells. Biochim. Biophys. Acta. 1356:1997;171-184.
34. Jiang Y., Song J., Zang Q., Foster D. Phosphatidylcholine-specific phospholipase D activity is elevated in v-Fps- transformed cells. Biochem. Biophys. Res. Commun. 203:1994;1195-1203.
35. Sy M. S., Guo Y. J., Stamenkovic I. Distinct effects of two CD44 isoforms on tumor growth in vivo. J. Exp. Med. 174:1991;859-866.
36. Thomas L., Byers R. H., Vink J., Stamenkovic I. CD44H regulates tumor migration on hyaluronate-coated surfaces. J. Cell. Biol. 118:1992;971-977.
37. Zheng Z., Katoh S., He Q., Miyake K., Lesley J., Hyman R., Hamik A., Parkhouse M., Farr A., Kinkade P. Monoclonal antibodies to CD44 and their influence on hyaluronan recognition. J. Cell Biol. 130:1995;485-495.
38. Okada H., Yoshida J., Sokabe M., Wakabayashi T., Hagiwara M. Suppression of CD44 expression decreases migration and invasion of human glioma cells. Int. J. Cancer. 66:1996;255-260.
39. Friedl P., Maaser K., Klein E., Niggemann B., Krohne G., Zanker K. Migration of highly aggressive MV3 melanoma cells in 3-dimensional collagen lattices results in local matrix reorganization and shedding of α2 and β1 integrins and CD44. Cancer Res. 57:1997;2061-2070.
40. Hao Lo S., Bo Chen L. Focal adhesion as a signal transduction organelle. Cancer Metast. Rev. 13:1994;9-24.
41. Goebeler M., Kaufmann D., Brocker E., Klein E. Migration of highly aggressive melanoma cells on hyaluronic acid is associated with functional changes, increased turnover and shedding of CD44 receptors. J. Cell Sci. 109:1996;1957-1964.
42. Wei Y., Lukashev M., Simon D., Bodary S., Rosemberg S., Doyle M., Chapman H. Regulation of integrin function by the urokinase receptor. Science. 273:1996;1551-1555.
43. Rusciano D., Burger M. Mechanisms of metastasis. Mol. Genet. Nerv. Syst. Tumors. 1993;357-369.
44. Nobes C., Hall A. Rho, Rac and Cdc42 GTPases regulate the assembly of multimolecular focal complexes associated with actin stress fibers, lamellipodia and filopodia. Cell. 81:1995;53-62.
45. Niedel J., Kuhn L., Vandenbark G. Phorbol diester receptor copurifies with protein kinase C. Proc. Natl. Acad. Sci. USA. 80:1983;36-40.
46. Caloca M., Fernández N., Lewin N., Ching D., Modali R., Blumberg P., Kazanietz M. Beta2-chimaerin is a high affinity receptor for the phorbol ester tumor promoters. J. Biol. Chem. 272:1997;26488-26496.
47. Ha K., Yeo E., Exton J. Lysophosphatidic acid activation of phosphatidylcholine-hydrolyzing phospholipase D and actin polymerization by a pertussis toxin-sensitive mechanism. Biochem. J. 303:1994;55-59.
48. Jiang H., Lu Z., Luo J., Wolfman A., Foster D. Ras mediates the activation of phospholipase D by v-src. J. Biol. Chem. 270:1995;6006-6009.